GEHC

$79.824.24%3.25

Ge Healthcare Technologies Inc (GEHC)

Date: O: H: L: C: Vol:

Precedente Chiudi:

$76.57

Aprire:

$77.68

Volume 24 ore:

1,457,465

Volume relativo:

0.37

Capitalizzazione di mercato:

$36.09B

Reddito:

$20.98B

Utile/perdita netta:

$1.98B

Rapporto P/E:

19.11

EPS:

$4.18

Flusso di cassa netto:

$1.52B

1W Prestazione:

+10.89%

1M Prestazione:

+24.16%

6M Prestazione:

+30.79%

1Y Prestazione:

+6.50%

Intervallo 1D:

$77.55$80.34

Intervallo di 1 settimana:

$70.17$78.22

Portata 52W:

$58.75$89.77

Profilo aziendale di Ge Healthcare Technologies Inc (GEHC)

Nome

Ge Healthcare Technologies Inc

Settore

Healthcare

Industria

Medical Devices

Telefono

833-735-1139

Indirizzo

500 WEST MONROE STREET, CHICAGO, USA

Dipendente

54,000

Prossima data di guadagno

null

Ultimi documenti SEC

SEC

Discussioni di GEHC su X

Confronta GEHC con ABT, MDT, SYK, BSX, EW

Azioni	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
GEHC Ge Healthcare Technologies Inc	$36.09B	$21.64B	$2.15B	$1.52B	$4.18
ABT Abbott Laboratories	$188.14B	$45.13B	$6.28B	$7.38B	$3.09
MDT Medtronic Plc	$125.68B	$37.54B	$5.23B	$5.43B	$3.73
SYK Stryker Corp	$116.80B	$26.30B	$3.62B	$4.57B	$8.63
BSX Boston Scientific Corp	$63.97B	$21.00B	$3.67B	$3.48B	$2.38
EW Edwards Lifesciences Corp	$54.68B	$6.51B	$1.00B	$1.09B	$1.84

Ge Healthcare Technologies Inc Azioni (GEHC) Upgrade e downgrade

Data	Azione	Analista	Modifica della valutazione
2026-10-20	Iniziato	Wolfe Research	Peer Perform
2026-10-07	Iniziato	Barclays	Overweight
2026-09-22	Iniziato	Needham	Buy
2026-07-09	Iniziato	BMO Capital Markets	Market Perform
2026-06-23	Iniziato	RBC Capital Mkts	Outperform
2026-05-21	Aggiornamento	UBS	Sell → Neutral
2026-04-30	Downgrade	Goldman	Buy → Neutral
2026-01-15	Downgrade	UBS	Neutral → Sell
2025-10-13	Iniziato	Barclays	Equal Weight
2025-10-07	Downgrade	Citigroup	Buy → Neutral
2025-05-05	Aggiornamento	UBS	Sell → Neutral
2025-03-11	Aggiornamento	Goldman	Neutral → Buy
2025-01-08	Aggiornamento	Jefferies	Hold → Buy
2024-09-26	Downgrade	UBS	Neutral → Sell
2024-09-18	Aggiornamento	BTIG Research	Neutral → Buy
2024-09-09	Iniziato	JP Morgan	Neutral
2024-08-06	Iniziato	Stifel	Buy
2024-05-30	Iniziato	Goldman	Neutral
2024-02-15	Iniziato	HSBC Securities	Buy
2024-02-12	Aggiornamento	UBS	Sell → Neutral
2023-11-30	Iniziato	Jefferies	Hold
2023-11-27	Downgrade	UBS	Neutral → Sell
2023-09-19	Iniziato	Citigroup	Buy
2023-08-25	Iniziato	Argus	Buy
2023-08-16	Iniziato	Wells Fargo	Overweight
2023-07-31	Iniziato	BofA Securities	Neutral
2023-06-27	Iniziato	Morgan Stanley	Equal-Weight
2023-05-16	Iniziato	Oppenheimer	Outperform
2023-04-26	Iniziato	UBS	Neutral
2023-04-19	Iniziato	Piper Sandler	Overweight
2023-04-10	Iniziato	BTIG Research	Neutral
2023-03-13	Iniziato	Evercore ISI	Outperform
2023-02-17	Iniziato	Mizuho	Buy
2023-01-19	Iniziato	Redburn	Buy

Ge Healthcare Technologies Inc Azioni (GEHC) Dati Finanziari

Periodo	FY 2025	FY 2024	FY 2023
Data di fine periodo	2025-12-31	2024-12-31	2023-12-31
Revenue USD (M)	20,625.00	19,672.00	19,552.00
Cost of revenue USD (M)	-	-	11,630.00
Gross profit USD (M)	8,248.00	8,205.00	7,922.00
Research and development USD (M)	1,260.00	1,311.00	1,205.00
Operating expenses USD (M)	5,485.00	5,580.00	5,487.00
Operating income USD (M)	2,763.00	2,625.00	2,435.00
Income before tax USD (M)	2,768.00	2,581.00	2,361.00
Income tax expense USD (M)	614.00	531.00	743.00
Net income USD (M)	2,154.00	2,050.00	1,614.00
Basic EPS USD/shares	4.56	4.37	3.05
Diluted EPS USD/shares	4.55	4.34	3.03
Basic weighted shares shares (M)	456.00	456.00	455.00
Diluted weighted shares shares (M)	458.00	459.00	458.00
Selling, general and administrative USD (M)	4,225.00	4,269.00	4,282.00

Ge Healthcare Technologies Inc Azioni (GEHC) insider trading

Hochman Rodney FMay 12 '26
Director
Transazione
Buy
Costo
$62.03
#Azioni
1,618
Valore ($)
100,365
#Azioni Totale
1,618
Yang Watkin Phoebe L.May 08 '26
Director
Transazione
Buy
Costo
$63.01
#Azioni
1,000
Valore ($)
63,006
#Azioni Totale
13,702
Stromberg William JMay 06 '26
Director
Transazione
Buy
Costo
$61.69
#Azioni
1,000
Valore ($)
61,689
#Azioni Totale
15,330
CULP H LAWRENCE JRMay 06 '26
Director
Transazione
Buy
Costo
$61.88
#Azioni
80,805
Valore ($)
5,000,076
#Azioni Totale
151,207
SACCARO JAMESMay 01 '26
Chief Financial Officer
Transazione
Buy
Costo
$60.60
#Azioni
3,310
Valore ($)
200,585
#Azioni Totale
87,471
Arduini Peter JApr 30 '26
President and CEO
Transazione
Buy
Costo
$59.92
#Azioni
4,169
Valore ($)
249,827
#Azioni Totale
259,424
Jimenez Frank RApr 30 '26
GC & Corporate Secretary
Transazione
Buy
Costo
$60.45
#Azioni
1,750
Valore ($)
105,788
#Azioni Totale
93,932
Kenneth StacherskiNov 24 '25
Former Officer
Transazione
Proposed Sale
Costo
$77.00
#Azioni
4,585
Valore ($)
353,045
#Azioni Totale
0
Kenneth StacherskiOct 27 '25
Former Officer
Transazione
Proposed Sale
Costo
$78.95
#Azioni
4,585
Valore ($)
361,993
#Azioni Totale
0

Commercio interno	Relazione	Data	Transazione	Costo	#Azioni	Valore ($)	#Azioni Totale
Hochman Rodney F	Director	May 12 '26	Buy	$62.03	1,618	100,365	1,618
Yang Watkin Phoebe L.	Director	May 08 '26	Buy	$63.01	1,000	63,006	13,702
Stromberg William J	Director	May 06 '26	Buy	$61.69	1,000	61,689	15,330
CULP H LAWRENCE JR	Director	May 06 '26	Buy	$61.88	80,805	5,000,076	151,207
SACCARO JAMES	Chief Financial Officer	May 01 '26	Buy	$60.60	3,310	200,585	87,471
Arduini Peter J	President and CEO	Apr 30 '26	Buy	$59.92	4,169	249,827	259,424
Jimenez Frank R	GC & Corporate Secretary	Apr 30 '26	Buy	$60.45	1,750	105,788	93,932
Kenneth Stacherski	Former Officer	Nov 24 '25	Proposed Sale	$77.00	4,585	353,045	0
Kenneth Stacherski	Former Officer	Oct 27 '25	Proposed Sale	$78.95	4,585	361,993	0

Ge Healthcare Technologies Inc Borsa (GEHC) Ultime notizie

Oct 29, 2026

ISRG Sales Jump 22%: Can Growth Stay Ahead of Procedure Volumes? - Zacks Investment Research

Oct 29, 2026

GEHC vs. HAE: Which Stock Is the Better Value Option? - Zacks Investment Research

Oct 29, 2026

Oct 28, 2026

GE HealthCare Technologies (GEHC) Q3 Earnings and Revenues Beat Estimates - Zacks Investment Research

Oct 28, 2026

Revenue reaches $5.51B as profits climb at GE HealthCare (GEHC). - Stock Titan

Oct 28, 2026

Oct 26, 2026

RadNet to acquire teleradiology provider Onrad - AuntMinnie

Oct 26, 2026

Why Is GE Aerospace (NYSE GE) Gaining Attention After Strong Q3 Results? - Kalkine Media

Oct 26, 2026

Oct 23, 2026

Global Computed Tomography (CT) Market by Application, Technology, Care Setting, and Product: Five-Year Forecast | Photon-Counting Scanners and AI Breathe New Life Into a Mature CT Market - GlobeNewswire Inc.

Oct 23, 2026

Why Did GE Vernova (NYSE:GEV) Face Pressure? - Kalkine Media

Oct 23, 2026

Can General Electric (NYSE:GE) Stand Out as Industrial Themes Shift? - Kalkine Media

Oct 23, 2026

Oct 22, 2026

Pramila Jayapal Stock Trades and Disclosures - TechGraph

Oct 22, 2026

GEHC Expands Theranostics Imaging With 5 Global Collaborations - Zacks Investment Research

Oct 22, 2026

Oct 21, 2026

Meta strikes deal to keep Mark Zuckerberg in California after wealth tax concerns - The Economic Times

Oct 21, 2026

GE Vernova’s (GEV) Q3 Pullback Reflects Profit-Taking Amid Sustained AI-Capex Demand - Yahoo Finance

Oct 21, 2026

Can Surging Engine Orders Lift GE Aerospace (NYSE:GE) Shares Again? - Kalkine Media

Oct 21, 2026

Here's What to Expect From GE HealthCare’s Next Earnings Report - Barchart.com

Oct 21, 2026

Oct 19, 2026

Do Engine Demand and a Swelling Backlog Keep GE Aerospace (NYSE:GE) in Focus? - Kalkine Media

Oct 19, 2026

Are Data-Center Power Orders Swelling for GE Vernova (NYSE:GEV)? - Kalkine Media

Oct 19, 2026

Oct 18, 2026

GE HealthCare Technologies Inc. Common Stock (GEHC) Financial Statements - Pluang

Oct 18, 2026

Oct 16, 2026

Vaso Stock Surges 149% in a Year: What's Behind the Rally? - Zacks Investment Research

Oct 16, 2026

ISRG Ahead of Q3 Earnings: Can Procedure Growth Sustain Momentum? - Zacks Investment Research

Oct 16, 2026

Digital X-ray Market - Global and Regional Analysis and Forecast, 2026-2036 | Mobile Imaging, AI Workflows, and Detector Innovation Drive Growth to $9.90 Billion - GlobeNewswire Inc.

Oct 16, 2026

Global Mobile X-ray Systems Market Analysis and Forecast, 2026-2036 | AI-Enabled Digital Imaging and Asia-Pacific Growth Drive a $4.00 Billion Market by 2036 - GlobeNewswire Inc.

Oct 16, 2026

Global Mobile C-Arm Market Analysis and Forecast, 2026-2036 | Market to Reach $3.71 Billion as Minimally Invasive Surgery, AI, and 3D Imaging Drive 5.35% CAGR - GlobeNewswire Inc.

Oct 16, 2026

Oct 12, 2026

Healthcare: Stocks Had a Great Q3, as Defensive Nature and Steady Innovation Drew Interest - Morningstar

Oct 12, 2026

A live call starts at 8:30 a.m. ET on Oct. 28, after GE HealthCare releases its results. - Stock Titan

Oct 07, 2026

Oct 05, 2026

GE HealthCare stock pre-market at EUR 57.22: minus 0.10 percent - ad-hoc-news.de

Oct 05, 2026

Oct 02, 2026

Securities Fraud Investigation Into GE HealthCare Technologies Inc. (GEHC) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz - GlobeNewswire Inc.

Oct 02, 2026

GEHC vs. SYK: Which Stock Should Value Investors Buy Now? - Zacks Investment Research

Oct 02, 2026

Oct 01, 2026

GE HealthCare Technologies (NasdaqGS:GEHC) Stock Forecast & Analyst Predictions - Simply Wall Street

Oct 01, 2026

Sep 30, 2026

GE HealthCare (GEHC) Upgraded to Buy: Here's Why - Zacks Investment Research

Sep 30, 2026

GE HealthCare stock pre-market at EUR 58.59: minus 0.02 percent - AD HOC NEWS

Sep 30, 2026

Sep 27, 2026

GE HealthCare Technologies (GEHC) Stock Price, News & Analysis - Stock Titan

Sep 27, 2026

Sep 23, 2026